CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes

被引:313
作者
Nelson, Brad H. [1 ,2 ,3 ]
机构
[1] British Columbia Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC V8R 6V5, Canada
[2] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada
[3] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada
关键词
KIDNEY-TRANSPLANT REJECTION; RENAL-ALLOGRAFT REJECTION; MEDULLARY BREAST-CANCER; T-CELLS; LUNG-CANCER; IMMUNE-RESPONSES; PROSTATE-CANCER; DENDRITIC CELLS; SYSTEMIC AUTOIMMUNITY; RHEUMATOID-ARTHRITIS;
D O I
10.4049/jimmunol.1001323
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor-infiltrating CD8(+) T cells are strongly associated with patient survival in a wide variety of human cancers. Less is known about tumor-infiltrating CD20(+) B cells, which often colocalize with T cells, sometimes forming organized lymphoid structures. In autoimmunity and organ transplantation, T cells and B cells collaborate to generate potent, unrelenting immune responses that can result in extensive tissue damage and organ rejection. In these settings, B cells enhance T cell responses by producing Abs, stimulatory cytokines, and chemokines, serving as local APCs, and organizing the formation of tertiary lymphoid structures that sustain long-term immunity. Thus, B cells are an important component of immunological circuits associated with persistent, rampant tissue destruction. Engagement of tumor-reactive B cells may be an important condition for generating potent, long-term T cell responses against cancer. The Journal of Immunology, 2010, 185: 4977-4982.
引用
收藏
页码:4977 / 4982
页数:6
相关论文
共 95 条
[1]   Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer [J].
Al-Shibli, Khalid I. ;
Donnem, Tom ;
Al-Saad, Samer ;
Persson, Magnus ;
Bremnes, Roy M. ;
Busund, Lill-Tove .
CLINICAL CANCER RESEARCH, 2008, 14 (16) :5220-5227
[2]   Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab [J].
Alausa, M ;
Almagro, U ;
Siddiqi, N ;
Zuiderweg, R ;
Medipalli, R ;
Hariharan, S .
CLINICAL TRANSPLANTATION, 2005, 19 (01) :137-140
[3]   B-cell-derived lymphotoxin promotes castration-resistant prostate cancer [J].
Ammirante, Massimo ;
Luo, Jun-Li ;
Grivennikov, Sergei ;
Nedospasov, Sergei ;
Karin, Michael .
NATURE, 2010, 464 (7286) :302-U187
[4]   B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion [J].
Barbera-Guillem, E ;
Nelson, MB ;
Barr, B ;
Nyhus, JK ;
May, KF ;
Feng, L ;
Sampsel, JW .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 48 (10) :541-549
[5]   Rituximab as treatment for refractory kidney transplant rejection [J].
Becker, YT ;
Becker, BN ;
Pirsch, JD ;
Sollinger, HW .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (06) :996-1001
[6]   Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice [J].
Bouaziz, Jean-David ;
Yanaba, Koichi ;
Venturi, Guglielmo M. ;
Wang, Yaming ;
Tisch, Roland M. ;
Poe, Jonathan C. ;
Tedder, Thomas F. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (52) :20878-20883
[7]   B cells and professional APCs recruit regulatory T cells via CCL4 [J].
Bystry, RS ;
Aluvihare, V ;
Welch, KA ;
Kallikourdis, M ;
Betz, AG .
NATURE IMMUNOLOGY, 2001, 2 (12) :1126-1132
[8]   Ectopic lymphoid tissues and local immunity [J].
Carragher, Damian M. ;
Rangel-Moreno, Javier ;
Randall, Troy D. .
SEMINARS IN IMMUNOLOGY, 2008, 20 (01) :26-42
[9]  
Chan O, 1998, J IMMUNOL, V160, P51
[10]  
Chan OTM, 1999, J IMMUNOL, V163, P3592